GlassScriptPhysician profile
Nguyen Ly
NPI 1023172020
$4,506.55
in general payments reported to CMS, 2019-2025
8 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2021: $16.48 · 2022: $1,982 · 2023: $1,734 · 2024: $156 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412 · Travel and Lodging: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.96 |
| Travel and Lodging | $909.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,871.55 | 2022-2023 | Acuvue |
| Alcon Vision LLC | $1,689.98 | 2019-2025 | Precision7, Total30 |
| Bausch & Lomb Americas INC. | $242.59 | 2023-2025 | Vyzulta, Lotemax Sm, Infuse |
| Coopervision INC. | $225.73 | 2022-2025 | Myday Contact Lens |
| Dompe US, INC. | $125.00 | 2023 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Apellis Pharmaceuticals, INC. | $121.24 | 2023 | |
| Glaukos Corporation | $105.46 | 2025 | Idosetr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nguyen Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.